{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:31:03Z","timestamp":1772461863040,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:p>Lung cancer is the leading cause of cancer-related deaths in the US, predominantly non-small cell lung cancer (NSCLC). Lymph node metastasis significantly impacts prognosis, yet current classification systems lack precision. Lymph node ratio (LNR), correlating metastatic to total lymph nodes, emerges as a superior prognostic tool. The study aimed to identify statistically validated LNR cutoffs and evaluate their prognostic significance in NSCLC patients, addressing limitations in the current tumor, node, and metastasis staging system. The study utilized data from the surveillance, epidemiology, and end results database (2010\u20132019) to analyze NSCLC patients undergoing tumor excision. Exclusions included those receiving chemotherapy or radiotherapy. Patients receiving chemotherapy or radiotherapy were excluded to isolate the independent impact of surgical lymph node retrieval on cancer-specific survival. The primary outcome focused on cancer-specific survival (CSS) stratified by LNR, with secondary analysis on N1\/N2 NSCLC cases. X-tile software determined LNR cutoffs, categorizing patients into 3 groups. Descriptive statistics and Kaplan\u2013Meier analysis were employed, along with multivariate Cox regression. Lower Akaike information criterion (AIC) values favored LNR models. Empower Stats and R software were utilized, with <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05 indicating significance. Median CSS follow-up was 22 months, with 1265 NSCLC-related deaths. Lymph node retrieval averaged 11, with a median LNR of 0.15. X-tile analysis revealed LNR thresholds of 0.17 and 0.34, stratifying patients into low, medium, and high-risk groups. Kaplan\u2013Meier show better differentiation when LNR is used as a predictor compared to N staging (LNR <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001 vs N stage <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.91). Multivariate Cox regression confirmed high LNR as an independent predictor of poorer CSS. A lower Akaike information criterion for LNR models highlighted its superior prognostic accuracy over N staging. This study demonstrates that the LNR is a superior prognostic indicator for N1 and N2 stage NSCLC compared to traditional N staging. By integrating metastatic burden and lymph node retrieval extent, LNR addresses key gaps in the tumor, node, and metastasis system and provides enhanced risk stratification. Clinicians can use LNR to identify high-risk patients who may benefit from intensified adjuvant therapies or tailored follow-up protocols. Further prospective studies are warranted to establish standardized LNR thresholds and validate its integration into clinical practice.<\/jats:p>","DOI":"10.1097\/md.0000000000042202","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:00:34Z","timestamp":1746529234000},"page":"e42202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Lymph node ratio emerges as a pivotal prognostic determinant for cancer-specific survival amidst individuals diagnosed with stage N1 and N2 non-small cell lung carcinoma: A population-based retrospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiaowei","family":"He","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Wuning County People\u2019s Hospital, Jiujiang City, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang City, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1166-078X","authenticated-orcid":false,"given":"Tao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang City, Jiangxi Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250904","first-page":"5","article-title":"Cancer statistics, 2015.","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet (London, England)"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jtho.2016.05.004","article-title":"A proposal for combination of lymph node ratio and anatomic location of involved lymph nodes for nodal classification in non-small cell lung cancer.","volume":"11","author":"Ding","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.rmed.2010.08.005","article-title":"Staging of non-small cell lung cancer (NSCLC): a review.","volume":"104","author":"Tsim","year":"2010","journal-title":"Respir Med"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jtho.2016.06.028","article-title":"The IASLC Lung Cancer Staging Project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (8th) edition of the TNM classification of lung cancer.","volume":"11","author":"Detterbeck","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1072-7515(98)00229-4","article-title":"The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification.","volume":"187","author":"Kodera","year":"1998","journal-title":"J Am Coll Surg"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00292-010-1307-0","article-title":"TNM classification of breast cancer: changes and comments on the 7th edition.","volume":"31","author":"Sinn","year":"2010","journal-title":"Der Pathologe"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00268-011-1360-8","article-title":"Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.","volume":"36","author":"Wang","year":"2012","journal-title":"World J Surg"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/SLA.0b013e31818842ec","article-title":"The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.","volume":"248","author":"Peschaud","year":"2008","journal-title":"Ann Surg"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.sla.0000250423.43436.e1","article-title":"The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.","volume":"245","author":"Marchet","year":"2007","journal-title":"Ann Surg"},{"key":"R12-20250904","doi-asserted-by":"crossref","first-page":"R680","DOI":"10.1186\/bcr934","article-title":"Ratios of involved nodes in early breast cancer.","volume":"6","author":"Vinh-Hung","year":"2004","journal-title":"Breast Cancer Res"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s12029-024-01046-2","article-title":"A prognostic model based on the log odds ratio of positive lymph nodes predicts prognosis of patients with rectal cancer.","volume":"55","author":"Li","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"R14-20250904","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12876-024-03462-x","article-title":"Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy.","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2009.02.024","article-title":"A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.","volume":"66","author":"Bria","year":"2009","journal-title":"Lung Cancer"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.chest.2024.06.3797","article-title":"Role of pathologic single-nodal and multiple-nodal descriptors in resected non-small cell lung cancer.","volume":"166","author":"Takamori","year":"2024","journal-title":"Chest"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12890-024-03313-1","article-title":"Number of involved nodal stations predicts survival in small cell lung cancer.","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Pulm Med"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7150\/jca.90525","article-title":"Lymph node ratio enhances predictive value for treatment outcomes in patients with non-small cell lung cancer undergoing surgery: a retrospective cohort study.","volume":"15","author":"Wang","year":"2024","journal-title":"J Cancer"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.3390\/jcm13154570","article-title":"Prognostic value of lymph node ratio (LNR) in patients with postoperative N2 feature in non-small cell lung cancer (NSCLC).","volume":"13","author":"\u0141ochowski","year":"2024","journal-title":"J Clin Med"},{"key":"R20-20250904","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12672-022-00542-w","article-title":"Lymph node ratio predicts overall survival in patients with stage II non-small cell lung cancer: a population-based SEER analysis.","volume":"13","author":"Feng","year":"2022","journal-title":"Discov Oncol"},{"key":"R21-20250904","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cllc.2013.04.012","article-title":"Classifications of N2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.","volume":"14","author":"Ito","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"R22-20250904","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jtcvs.2013.12.058","article-title":"Demonstration of the skip metastasis pathway for N2 non-small cell lung cancer.","volume":"147","author":"Takizawa","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R23-20250904","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5578\/tt.5987","article-title":"Determination of sentinel lymph node by Tc(99m) in small-cell lung cancer.","volume":"62","author":"Zeybek","year":"2014","journal-title":"Tuberk Toraks"},{"key":"R24-20250904","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1245\/s10434-023-14072-4","article-title":"Long-term outcomes of selected patients with IIIA-N2 non-small cell lung cancer receiving upfront surgical resection.","volume":"30","author":"Fu","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R25-20250904","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lungcan.2023.01.008","article-title":"Reaching multidisciplinary consensus on the management of non-bulky\/non-infiltrative stage IIIA N2 non-small cell lung cancer.","volume":"177","author":"Scherpereel","year":"2023","journal-title":"Lung Cancer"},{"key":"R26-20250904","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/JTO.0b013e31811f4703","article-title":"The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (7th) edition of the TNM classification of lung cancer.","volume":"2","author":"Postmus","year":"2007","journal-title":"J Thorac Oncol"},{"key":"R27-20250904","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12957-016-1048-5","article-title":"Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.","volume":"14","author":"Tamura","year":"2016","journal-title":"World J Surg Oncol"},{"key":"R28-20250904","first-page":"702","article-title":"Correlation between lymph node ratio and clinicopathological features and prognosis of IIIa-N2 non-small cell Lung cancer.","volume":"22","author":"Zhang","year":"2019","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"R29-20250904","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1200\/JCO.2009.24.0044","article-title":"Lymph node ratio better predicts disease-free survival in node-positive breast cancer than the number of positive lymph nodes.","volume":"27","author":"Van Belle","year":"2009","journal-title":"J Clin Oncol"},{"key":"R30-20250904","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1245\/s10434-010-1528-8","article-title":"Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer.","volume":"18","author":"Qiu","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R31-20250904","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/JTO.0b013e318292c53e","article-title":"Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.","volume":"8","author":"Urban","year":"2013","journal-title":"J Thorac Oncol"},{"key":"R32-20250904","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/SLA.0b013e3181f9b8b6","article-title":"Lymph node ratio provides prognostic information in addition to American joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized.","volume":"253","author":"Spillane","year":"2011","journal-title":"Ann Surg"},{"key":"R33-20250904","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thx.2010.148601","article-title":"Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer.","volume":"66","author":"Wisnivesky","year":"2011","journal-title":"Thorax"},{"key":"R34-20250904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fsurg.2024.1506850","article-title":"Comparative evaluation of negative lymph node count, positive lymph node count, and lymph node ratio in prognostication of survival following completely resection for non-small cell lung cancer: a multicenter population-based analysis.","volume":"11","author":"Huang","year":"2024","journal-title":"Front Surg"},{"key":"R35-20250904","doi-asserted-by":"crossref","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","article-title":"NCCN guidelines\u00ae insights: non-small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines.","volume":"21","author":"Ettinger","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"R36-20250904","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cncr.24853","article-title":"Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?","volume":"116","author":"Schreiber","year":"2010","journal-title":"Cancer"},{"key":"R37-20250904","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/ejcts\/ezab287","article-title":"The prognostic value of lymph node ratio in patients with surgically resected stage I\u2013III small-cell lung cancer: a propensity score matching analysis of the SEER database.","volume":"60","author":"Yang","year":"2021","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:02:09Z","timestamp":1756987329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":37,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042202","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}